Ad
related to: promethazine 25 mg tablet images and pictures of women free
Search results
Results From The WOW.Com Content Network
Promethazine, sold under the brand name Phenergan among others, is a first-generation antihistamine, sedative, and antiemetic used to treat allergies, insomnia, and nausea. It may also help with some symptoms associated with the common cold [ 4 ] and may also be used for sedating people who are agitated or anxious, an effect that has led to ...
0.125, 0.25 0.5: 0.5–2: 2: hypnotic: Drug Name Common Trade Names Year Approved Typical Dosages of Oral Tablets (mg) Approx. Equivalent Oral Dose to 10mg Diazepam (mg) Peak onset of action (hours) Elimination Half-life of Active Metabolite (hours) Primary Therapeutic Use
This pharmacology -related article is a stub. You can help Wikipedia by expanding it.
In 1947, it synthesized promethazine, a phenothiazine derivative, which was found to have more pronounced sedative and antihistaminic effects than earlier drugs. [ 59 ] : 77 A year later, the French surgeon Pierre Huguenard used promethazine together with pethidine as part of a cocktail to induce relaxation and indifference in surgical patients.
The following other wikis use this file: Usage on ar.wikipedia.org بروميثازين; Usage on azb.wikipedia.org پرومتازین; Usage on bn.wikipedia.org
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Brotizolam [3] (marketed under brand name Lendormin) is a sedative-hypnotic [4] thienotriazolodiazepine [5] drug which is a benzodiazepine analog. [6] It possesses anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties, and is considered to be similar in effect to other short-acting hypnotic benzodiazepines such as triazolam or midazolam. [7]
Two women, each claiming to have suffered severe medical complications from a generic version of metoclopramide, lost their Supreme Court appeal on June 23, 2011. In a 5–4 ruling in PLIVA, Inc. v. Mensing , [ 70 ] [ 71 ] the court held that generic companies cannot be held liable for information, or the lack of information, on the originator ...